Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Top Cited Papers
Open Access
- 25 May 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 56 (1), 52-59
- https://doi.org/10.1093/jac/dki166
Abstract
Enterobacteriaceae, especially Klebsiella spp. producing extended-spectrum β-lactamases (ESBLs) such as SHV and TEM types, have been established since the 1980s as a major cause of hospital-acquired infections. Appropriate infection control practices have largely prevented the dissemination of these bacteria within many hospitals, although outbreaks have been reported. However, during the late 1990s and 2000s, Enterobacteriaceae (mostly Escherichia coli) producing novel ESBLs, the CTX-M enzymes, have been identified predominantly from the community as a cause of urinary tract infections. Resistance to other classes of antibiotics, especially the fluoroquinolones, is often associated with ESBL-producing organisms. Many clinical laboratories are still not aware of the importance of screening for ESBL-producing Enterobacteriaceae originating from the community. A heightened awareness of these organisms by clinicians and enhanced testing by laboratories, including molecular surveillance studies, is required to reduce treatment failures, to limit their introduction into hospitals and to prevent the spread of these emerging pathogens within the community.Keywords
This publication has 71 references indexed in Scilit:
- Etiology and Antibiotic Susceptibility Patterns of Community-Acquired Urinary Tract Infections in a Kuwait HospitalMedical Principles and Practice, 2004
- Prevalence of extended spectrum β-lactamase producing escherichia coli and klebsiella isolates in a large community teaching hospital in connecticutDiagnostic Microbiology and Infectious Disease, 2004
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- Ciprofloxacin and co-trimoxazole resistance and extended spectrum β-lactamase production in Escherichia coli strains isolated from urinary tract infectionsInternational Journal of Antimicrobial Agents, 2003
- Bacterial Resistance: Origins, Epidemiology, and ImpactClinical Infectious Diseases, 2003
- Characterization of a Chromosomally Encoded Extended-Spectrum Class A β-Lactamase from Kluyvera cryocrescensAntimicrobial Agents and Chemotherapy, 2001
- Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance ThreatClinical Microbiology Reviews, 2001
- Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1FEMS Microbiology Letters, 2001
- Antibiotic Susceptibility of Bacterial Strains Isolated from Patients with Community-Acquired Urinary Tract Infections in FranceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Editorial Response: Extended-Spectrum -Lactamases: A Call for Improved Detection and ControlClinical Infectious Diseases, 1999